Skip to main content Skip to section menu

Research portfolio (by researcher)

Our members consistently produce high-quality research in top peer-reviewed medical and scientific journals. Below are lists of individual members and their selected publications and funding achievements. [*joint first author]

Prof Andrew Lemmey

Selected publications: (total n≈60)

  1. Wilkinson, T.J., O'Brien T.D., and Lemmey A.B. Oral creatine supplementation; a potential adjunct therapy for rheumatoid arthritis.  Under review by World Journal of Rheumatology (invited review). 
  2. Metsios, G.S. and Lemmey A.B. Exercise as medicine in rheumatoid arthritis: effects on function, body composition and body composition. Under review by Journal of Clinical Exercise Physiology (invited review).
  3. Okoro, T., Morrison, V., Maddison, P.J., Lemmey, A.B. and Andrew, J.G. An assessment of the impact of behavioural cognitions on function in patients partaking in a trial of early home-based progressive resistance training after total hip replacement surgery.  Disability and Rehabilitation. Disabil Rehabil. (2013) 35(23):2000-2007. doi: 10.3109/09638288.2013.770082. Epub 2013 Mar 13
  4. Junglee N., Di Felice U., Dolci A., Fortes M., Jibani M., Lemmey A.B., Walsh N., and Macdonald J.M.  Exercising in a hot environment with muscle damage: effects on acute kidney injury biomarkers and kidney function.   Accepted by American Journal of Physiology - Renal Physiology (F-00091-2013R2).
  5. Cooney J.K., Moore J.P., Ahmad Y.A., Jones J.G., Lemmey A.B., Casanova F., Maddison P.J. and Thom J.M. A simple step test to estimate cardio-respiratory fitness levels of rheumatoid arthritis patients in a clinical setting.   International Journal of Rheumatology 01/2013; 2013:174541. DOI:10.1155/2013/174541
  6. Lemmey A.B. and Okoro T. The efficacy of exercise rehabilitation in restoring physical function following total hip replacement for osteoarthritis: A review.  Clinical Medical Insights: Therapeutics (2013) 5:151-162. Invited review.
  7. Okoro T., Stewart C., Al-Shanti N., Lemmey A.B., Maddison P.J., and Andrew J.G.  Does muscle inflammation influence recovery of muscle strength and function in patients undergoing total hip replacement?  The Lancet (2013) 381:S82. DOI:10.1016/S0140-6736(13)60522-X
  8. Lemmey A.B., Elamanchi S.R., Marcora S.M., Casanova F., and Maddison P.J.  Efficacy of nandrolone decanoate in treating rheumatoid cachexia in male rheumatoid arthritis patients. In: Innovative Rheumatology  (ISBN 978-953-51-0916-7).  InTech (www.intechweb.org) (2013) 271-285.
  9. Junglee N., Lemmey A.B., Burton M., Searell C., Lawley J., Jibani M. and Macdonald J.M.   Does proteinuria-inducing physical activity increase biomarkers of acute kidney injury?  Kidney & Blood Pressure Research (2012) 36(1):278-289.Okoro T., Lemmey A.B., Maddison P.J. and Andrew J.G.  Review: An appraisal of rehabilitation regimes used for improving functional outcome after total hip replacement surgery. Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology (2012) 4(5):7.
  10. Lemmey A.B., Williams S.L., Marcora S.M., Jones J. and Maddison  P.J.  Are the benefits of a high intensity resistance training program sustained in rheumatoid arthritis patients?  A 3 year follow-up study.    Arthritis Care & Research (2012) 64(1):71-75.
  11. Matschke V., Thom J.M., Lemmey A.B., Maddison P.J. and Jones J.G. Adverse changes in tendon-muscle physiology and physical function caused by an isolated acute rheumatoid knee effusion: a case study.  Arthritis Care & Research (2012) 64(1):117-121.
  12. Lemmey A.B., Jones J. and Maddison  P.J.  Rheumatoid cachexia: What is it and why is it important?  The Journal of Rheumatology (2011) 38:2074-2075.
  13. Lemmey A.B.  Efficacy of progressive resistance training for patients with rheumatoid arthritis, and recommendations regarding its prescription: A review.  International Journal of Clinical Rheumatology (2011) 6(2):189-205. Invited review.
  14. Matschke V., Murphy P., Lemmey A.B., Maddison P.J. and Thom J.M.  Skeletal muscle properties in rheumatoid arthritis patients.  Medicine and Science in Sports and Exercise (2010) 42(12):2149-2155.
  15. Matschke V., Murphy P., Lemmey A.B., Maddison P.J. and Thom J.M.  Muscle quality, architecture and activation in cachectic rheumatoid arthritis patients.  Journal of Rheumatology (2010) 37(2):282-284.
  16. Lemmey A.B., Marcora S.M., Chester K., Wilson S., Casanova  F. and Maddison  P.J.  Effects of high intensity resistance training in rheumatoid arthritis patients – a randomised, controlled trial.  Arthritis & Rheumatism (2009) 61(12):1726-1734.
  17. Macdonald J., Marcora S., Jibani M., Kumwenda M., Ahmed W. and Lemmey A.  Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomised phase II dose finding study.  Nephron Clinical Practice (2007) 106(3):125-135.
  18. Marcora S.M., Chester K., Mittal G., Lemmey A.B. and Maddison P.J.  A randomized phase II trial of anti-TNF therapy for cachexia in patients with early rheumatoid arthritis.  American Journal of Clinical Nutrition (2006) 84:1463-1472.
  19. Marcora S.M., Casanova  F., Williams E., Jones J., Elamanchi R. and Lemmey A.B.  Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis.  Rheumatology (2006) 45(11):1385-1388.
  20. Macdonald J.H., Marcora S.M., Jibani M., Roberts G., Kumwenda M.J., Glover R., Barron J., and Lemmey A.B.  Glomerular filtration rate estimation using cystatin C is not independent of body composition.  American Journal of Kidney Diseases (2006) 48(5):712-719.
  21. Macdonald J.H., Marcora S.M., Kumwenda M.J., Jibani M., Roberts G., Glover R., Barron J., and Lemmey A.B.  Bioelectrical impedance can be used to predict muscle mass and hence improve estimation of glomerular filtration rate in patients with chronic kidney disease.  Nephrology, Dialysis and Transplantation (2006) 21(12):3481-3487.
  22. Macdonald J.H., Marcora S.M., Kumwenda M.J., Jibani M., Roberts G., Glover R., Barron J., and Lemmey A.B.  The relationship between estimated glomerular filtration rate, demographic and anthropometric variables is mediated by muscle mass in patients with chronic kidney disease.  Nephrology, Dialysis and Transplantation (2006) 21(12):3488-3494.
  23. Marcora S.M., Oliver S., Callow N., Lemmey A.B. and Stuart N. Resistance exercise as adjunct treatment in prostate cancer patients receiving luteinizing hormone-releasing hormone agonists. Journal of Urology (2005) 174(5):2068-2069.
  24. Marcora S.M, Maddison P.J. and Lemmey A.B.  Dietary treatment of rheumatoid cachexia with ß-hydroxy-ß-methylbutyrate, glutamine and arginine: a randomised controlled trial.  Clinical  Nutrition (2005) 24(3):442-454.
  25. Marcora S.M., Lemmey A.B. and Maddison P.J.  Can progressive resistance training reverse cachexia in rheumatoid arthritis patients?  A pilot study.  Journal of Rheumatology (2005) 32(6):1031-1039.
  26. Macdonald J.H., Marcora S.M., Jibani M., Phanish M.K., Holly J.M.P. and Lemmey A.B.  Intradialytic exercise as anabolic therapy in haemodialysis patients-a pilot study.  Clinical Physiology and Functional Imaging (2005) 25:113-118. 

Book chapters:

  1. Lemmey A.B.  Chapter 22  Arthritis, Clinical Exercise Physiology (3rd Edition), edited by Ehrman J.K., Gordon P.M., Visich P.S. & Keteyian S.J.  Human Kinetics.  Published 2013.  [note: this is the leading clinical exercise physiology text in the world, and is the core text for the American College of Sports Medicine's Registered Clinical Exercise Physiologist (ACSM RCEP} qualification.  Of the 57 contributors to the 3rd edition, only 2 were not US-based].
  2. Invited to write the chapter on Arthritis, ACSM's Guidelines for Exercise Testing and Prescription (10th edition), due to be published in 2015.  [The leading text in this field in the world].

Selected grants: running total ≈ £2 million

  1. HTA: £576,332 (2012-2016).  Developing a multidisciplinary rehabilitation package following total hip replacement surgery for hip fracture. Dr. Nefyn Williams, Prof. Andrew Lemmey, Prof. Clare Wilkinson, Prof. Bob Woods, Mr. Chris Whitaker, Prof. Rhiannon Tudor-Edwards, Dr. Val Morrison, Prof. Jo Rycroft-Malone, Prof. Catherine Sackley, Mr. Glynne Andrew, Mr. Tosan Okoro.
  2. Welsh Assembly Government WCAT Scheme; Wales Clinical Academic Track Award: £56,640 (2011-2012).  Optimising patient function following elective total hip replacement (THR) surgery.  Dr. Andrew Lemmey, Prof. Peter Maddison, Mr. Tosan Okoro.
  3. NISCHR RRG: £458,379 (2010-present).  Welsh Arthritis Research Network (WARN).  Dr. Stefan Siebert, Prof. Peter Maddison, , Dr. Andrew Lemmey, Mr. Ian Pallister, Dr. Rhian Goodfellow, Dr. Mark Ridgewell, Dr. Robert van Deursen, Dr. Valerie Sparkes, Prof. Ian Russell, Ms. Rhiannon Whittaker, Ms. Anne Breslin, Ms. Suzanne Morris, Dr. Sinead Brophy, Dr. Mike Kingsley.
  4. WORD Health Studentship award: £59,706 (2009-2011). Cardiovascular fitness in patients with rheumatoid arthritis.  Dr. Jeanette Thom, Dr. Yasmeen Ahmad, Dr. Jonathon Moore, Dr. Andrew Lemmey, Prof. Peter Maddison
  5. Lupus UK: £45,384 (2004-6).  Physiological causes of poor aerobic capacity and fatigue in systemic lupus erythematosus.  Prof. Peter Maddison, Dr. Samuele Marcora, Dr. Andrew Lemmey
  6. Arthritis Research Campaign: £57,948 (2004-5).  Effects of resistance training in cachectic rheumatoid arthritis patients.  Dr. Andrew Lemmey, Prof. Peter Maddison, Prof. Jeff Holly, Samuele Marcora
  7. Organon: ~£20,620 (nandrolone decanoate plus placebo) (2004-5).  Nandrolone decanoate as adjunct therapy in patients with rheumatoid arthritis.  Dr. Andrew Lemmey, Dr. Rao Elamanchi, Prof. Peter Maddison, Samuele Marcora
    Nandrolone decanoate: a dose response curve in patients with renal failure.  Dr. Andrew Lemmey, Jamie Macdonald, Dr. Mick Kumwenda, Dr. Samuele Marcora, Dr. Mahdi Jibani.
  8. National Kidney Research Fund: £26,750 (start-up grant RP34/1/2004).  Estimating glomerular filtration rate using measured muscle mass.  Dr. Andrew Lemmey, Samuele Marcora, Dr. Mahdi Jibani, Dr. Lionel Bloodworth, Jamie Macdonald 
  9. Wyeth Pharmaceuticals: £115,000 (2002-4).  The role of anti-TNF therapy with etanercept in the prevention of rheumatoid cachexia.   Prof. Peter Maddison, Samuele Marcora, Prof. Jeff Holly, Dr. Andrew Lemmey
  10. MTI BioTech, Inc: £30,000 (2000-2).  Anabolic effects of a nutritional mixture of ß-hydroxy ß-methylbutyrate (HMB), arginine and lysine in rheumatoid arthritis patients.  Dr. Andrew Lemmey, Samuele Marcora, Prof. Peter Maddison, Prof. Jeff Holly
  11. Medical Research Council (MRC): 2000 Joint Research Equipment Initiative: £26,290 (2000).      i) Humoral mediators of muscle wasting in rheumatoid arthritis (RA)  ii) Effects of resistance training in cachectic RA patients  iii) Effects of a nutritional mixture of HMB, glutamine and arginine in RA patients.  Dr. Andrew Lemmey, Prof. Peter Maddison, Prof. Jeff Holly, Samuele Marcora

Dr Thomas O'Brien

Selected publications:

  1. O'Brien TD, Reeves ND, Baltzopoulos V, Jones DA, Maganaris CN. 2010. Mechanical properties of the patellar tendon in adults and children. J Biomech, vol. 43(6), 1190-1195.
  2. O'Brien TD, Reeves ND, Baltzopoulos V, Jones DA, Maganaris CN. 2010. In vivo measurements of muscle specific tension in adults and children. Experimental Physiology, vol. 95(1), 202-210.
  3. O'Brien TD, Reeves ND, Baltzopoulos V, Jones DA, Maganaris CN. 2009. Moment arms of the knee extensor mechanism in children and adults. J Anat, vol. 215(2), 198-205.
  4. O'Brien TD, Reeves ND, Baltzopoulos V, Jones DA, Maganaris CN. 2009. Strong relationships exist between muscle volume, joint power and whole-body external mechanical power in adults and children. Exp Physiol, vol. 94(6), 731-738.
  5. Alcock L, Vanicek N, O'Brien TD. 2014. Biomechanical demands differentiate transitioning vs. continuous stair ascent gait in older women. Clinical Biomechanics, vol. 29(1), 111-118.

Selected grants:

  1. Testing the differential recruitment theory of children's muscle function, Early Career Researcher Fellowship, LJMU, Jan 2013.
    Wellbeing, health and fitness of children with mobility impairments (Well MI); individually tailored child-centred 'keep-fit' interventions, National Institute for Social Care and Health Research, £208,192, September 2012.
  2. Can creatine supplementation improve body composition and physical function in rheumatoid arthritis patients? A pilot randomised control trial, Betsi Cadwaladr University Health Board (Local NHS), £17,290, December 2011.

Dr Aamer Sandoo

Selected publications:

  1. Sandoo A, Kitas GD, Carmichael AR.  Endothelial dysfunction as a mediator of trastuzumab-mediated cardiotoxicity in patients with breast cancer. Anticancer Research. 2014; 34(3): 1147 – 51.
  2. Dimitroulas T, Sandoo A, Kitas GD. Asymmetric dimethylarginine is not associated with subendocardial viability ratio in rheumatoid arthritis. International Journal of Cardiology. 2014; 172(1); 285 – 6.
  3. Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stravropolous-Kalinoglou A, Kitas GD. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology. 2014; 53(1): 131 – 7.
  4. Metsios GS, Stavropolous-Kalinoglou A, Veldhuijzen van zanten JJCS, Nightingale P, Sandoo A, Dimitroulas T, Kitas GD. Individual exercise improves endothelial function in patients with rheumatoid arthritis. Annal of Rheumatic Diseases. 2014; 73(4): 748 – 51.
  5. Sandoo A, Chanchlani N, Hodson J, Smith JP, Douglas KM, Kitas GD. Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six year prospective study. Arthritis Research and Therapy. 2013; 15(6): R203.
  6. Sandoo A, Hodson J, Douglas KM, Smith JP, Kitas GD. The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research and Therapy. 2013; 15(5): R107.
  7. Sandoo A, Kitas GD. Current perspectives on the assessment of vascular function and morphology in rheumatoid arthritis. Int J Clin Rheumatol. 2013; 8(1): 1-3.
  8. Dimitroulas T, Sandoo A*, Veldhuijzen van Zanten JJCS, Smith JPS, Metsios GS, Stravropolous-Kalinoglou A, Kitas GD. Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scand J Rheumatol. 2013; 42(3): 176-81.
  9. Dimitroulas T, Sandoo A, Kitas GD. Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with rheumatic diseases. International Journal of Molecular Sciences. 2012; 13(10): 12315-35.
  10. Sandoo A, Protogerou AD, Hodson J, Smith JP, Zampeli E, Sfikakis PP, Kitas GD. The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Research and Therapy. 2012; 14(6): R258.
  11. Sandoo A, Veldhuijzen van Zanten JJCS, Toms TE, Carroll D, Kitas GD. Anti-TNFalpha therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. BMC Musculoskeletal Disorders. 2012; 13(1): 127.
  12. Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJCS, Smith JP, Kitas GD. Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis. Clinical Biochemistry. 2012; 45(16-17): 1399 – 403.
  13. Sandoo A, Kitas GD, Carroll D, Veldhuijzen van Zanten JJCS.  The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Research & Therapy. 2012; 14(3): R117.
  14. Sandoo A, Dimitroulas T, Veldhuijzen van Zanten JJCS, Smith JP, Metsios GS, Nightingale P, Stavropolous-Kalinoglou A, Kitas GD. Lack of association between asymmetric dimethylarginine and in vivo microvascular & macrovascular endothelial function in patients with rheumatoid arthritis. Clinical Experiments in Rheumatology. 2012; 30(3): 388-96.
  15. Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2011; 50(11): 2125-39.
  16. Metsios GS, Stavropoulos-Kalinoglou A, Treharne GJ, Nevill AM, Sandoo A, Panoulas VF, Toms TE, Koutedakis Y, Kitas GD. Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Research & Therapy. 2011; 13(3): R108.
  17. Sandoo A, Carroll D, Metsios GS, Kitas GD, Veldhuijzen van Zanten JJCS. The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy. 2011; 13(3): R99.
  18. Sandoo A, Panoulas VF, Toms TE, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Gasparyan AY, Carroll D, Veldhuijzen van Zanten JJCS, Kitas GD. Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. Journal of Human Hypertension. 2011; 25(11): 699-702
  19. Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. The Open Cardiovascular Medicine Journal. 2010; 23(4): 302-12.
  20. Metsios GS, Stavropolous-Kalinoglou A, Panoulas VF, Sandoo A, Toms TE, Nevill AM, Koutedakis, Y, Kitas GD.  Rheumatoid cachexia and cardiovascular disease. Clinical Experiments in Rheumatology. 2010; 27(6): 985-8.
  21. Gasparyan AY, Sandoo A, Stavropolous-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF therapy. Rheumatology International. 2010; 30(8): 1125-9.
  22. Metsios GS, Stavropolous-Kalinoglou A, Sandoo A, Veldhuijzen van Zanten JJCS, Toms T, John H, Kitas GD.  Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. The Open Cardiovascular Medicine Journal. 2010; 23(4): 89-96.
  23. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo, Tentolouris N, Mavrikakis M, Sfikakis PP. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arteriosclerosis Thrombosis and Vascular Biology. 2009; 29(10): 1702-8
  24. Sandoo A, Toms T, Veldhuijzen van Zanten JJCS, Carroll D, Kitas GD. Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: Comment on the article by Gonzalez-Juanatey et al. Arthritis and Rheumatism. 2009; 61: 854-855.
  25. Veldhuijzen van Zanten JJCS, Sandoo A, Kitas GD. Carotid intima-media thickness as a predictor for cardiovascular events in patients with rheumatoid arthritis. Commentary in International Atherosclerosis Society. 2008; http://www.athero.org/commentaries/comm805.asp

Prof Peter Maddison

Selected publications:

  1. Angela E. Gliddon, Caroline J. Dore, Peter J. Maddison. Arthritis Care & Research, 2006, 55(3), pp 473-479. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis
  2. Maddison P. Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. Rheumatology 41: 965-971, 2002 2.
  3. Maddison P, Farewell V, Isenberg D, Aranow Cynthia, Bae S-C, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29: 913-7, 2002
  4. Lemmey AB, Maddison PJ, Whellams EJ and Holly JMP. Insulin-like Growth Factor (IGF) status of rheumatoid arthritis patients. J Rheumatol, 28:29-34, 2001 4.
  5. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MIV, Jimenez SA, Krieg T, LeRoy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H. A Disease Severity Scale for systemic sclerosis: Development and testing. J Rheumatol, 26: 2159-67, 1999 5.
  6. Julkunen H, Kaaja R, Siren M-K, Mack C, McCready S, Holthofer H, Kurki P, Maddison P. Immune mediated congenital heart block (CHB): Counselling pregnancies and identifying risk factors for CHB. Seminars Arthritis Rheum 28: 97-106, 1998 6.
  7. Harvey G, Black C, Maddison P, McHugh N. Characterization of antinucleolar antibody reactivity in patients with SSc and their relatives. J Rheumatol 24: 477-84, 1997.

Selected grants:

  1. ARC Clinical Trials Collaboration. P Maddison. Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition (the QUINS trial). £261,837. 2000-5
  2. North West Wales NHS Trust: Ross Research Fellowship. P Maddison, A Lemmey. Prevention of muscle loss in rheumatoid arthritis and other chronic disorders. £50,000. 2002-4
  3. Wyeth Pharmaceuticals. P Maddison, A Lemmey, J Holly, S Marcora. The role of anti-TNF therapy with etanercept in the prevention of rheumatoid cachexia. £105,000. 2002-3
  4. MTI BioTech, Inc. S Marcora, A Lemmey, P Maddison, J Holly. Anabolic effects of a nutritional mixture of ß-hydroxy ß-methylbutyrate (HMB), arginine and glutamine in rheumatoid arthritis patients. £30,000. 2000-2

Dr Yasmeen Ahmad

Dr Jeremy Jones

Selected publications:

  1. Improved access and targeting of musculoskeletal services in northwest Wales: targeted early access to musculoskeletal services (TEAMS) programme. Peter Maddison, Jeremy Jones, Anne Breslin, Craig Barton, Joyce Fleur, Rhian Lewis, Luke McSweeney, Carys Norgain, Sara Smith, Carolyn Thomas, Chris Tilson. British Medical Journal 2004; 329: 1325-1327.
  2. Benefits of exercise in rheumatoid arthritis. Cooney JK, Law R-J , Matschke, V Lemmey AB, Moore JP, Ahmad Y, Jones JG , Maddison P, Thom J M Journal of Aging Research Volume 2011 (2011), Article ID 681640, 14 pages. doi:10.4061/2011/681640
  3. "Activity Increase Despite Arthritis (AIDA): design of a Phase II randomised controlled trial evaluating an active management booklet for hip and knee osteoarthritis [ISRCTN24554946]". Nefyn H Williams, Elvis Amoakwa, Kim Burton, Maggie Hendry, John Belcher, Ruth Lewis, Kerenza Hood, Jeremy Jones, Paul Bennett, Rhiannon T Edwards, Richard D Neal, Glynne Andrew and Clare Wilkinson. BMC Family Practice 2009, 10:62 doi:10.1186/1471-2296-10-62
  4. The Hip and Knee Book: developing an active management booklet for hip and knee osteoarthritis. Nefyn H Williams, Elvis Amoakwa, Kim Burton, Maggie Hendry, Ruth Lewis, Jeremy Jones, Paul Bennett, Richard D Neal, Glynne Andrew, Clare Wilkinson Br J Gen Pract. 2010 February 1; 60(571): e64–e82. doi:10.3399/bjgp10X483166
  5. Activity Increase Despite Arthritis (AÏDA): phase II randomised controlled trial of an active management booklet for hip and knee osteoarthritis in primary care. Williams, Nefyn H; Amoakwa, Elvis; Belcher, John; Edwards, Rhiannon T; Hassani, Hossein; Hendry, Maggie; Burton, Kim; Lewis, Ruth; Hood, Kerenza; Jones, Jeremy; Bennett, Paul; Linck, Pat; Neal, Richard D; Wilkinson, Clare BJGP 2011.61;498-499
  6. Rheumatoid Cachexia: What is it and why is it so important? Lemmey A, Jones J. Maddison PJ. J Rheumatol 2011:38;2074
  7. Are the benefits of a high-intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3-year follow up study. Lemmey AB, Williams SL, Marcora SM, Jones J, Maddison, PJ Arthritis Care & Research 2012: 64; 71-75
  8. Adverse changes in tendon–muscle physiology and physical function caused by an isolated acute rheumatoid knee effusion: A case study. Matschke V, Thom JM, Lemmey AB, Maddison PL, Jones JG. Arthritis Care & Research 2012: 64; 117-121
  9. How do physiotherapists assess and treat patellofemoral pain syndrome in North Wales? A mixed method study. Papadopoulos K, Noyes J, Barnes M, Jones J, Thom J. International Journal of Therapy and Rehabilitation, May 2012, Vol 19, No 5: (1-12)
  10. Patellar Tendon Properties and Lower Limb Function in Rheumatoid Arthritis and Ankylosing Spondylitis versus Healthy Controls: A Cross-Sectional Study. Verena Matschke, Jeremy G. Jones, Andrew B. Lemmey, Peter J.Maddison, and Jeanette M. Thom. The Scientific World Journal, Vol 2013, Article ID 514743, 8 pages.

Book chapters:

J.G.Jones. The Biochemistry of Articular Disorders in Clinical biochemistry; Metabolic and clinical aspects (third edition) W J Marshall and SK Bangert Churchill Livingstone 2014 Churchill Livingstone, Edinburgh.

Dr Sarang Chilate

Selected publications:

  1. Chitale S, (Ciapetti A, Hodgson R, Grainger A, O'Connor P,) Goodson NG, Thompson RN, Estrach C, Moots RJ, (Grassi W) and Anderson ME (2010) 'Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterise covert inflammatory arthropathy in systemic sclerosis patients with arthralgia'. Rheumatology

Site footer